Lyrical Asset Management LP Sells 8,223 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Lyrical Asset Management LP has reduced its holdings in HCA Healthcare by 1.1%, now owning 763,468 shares valued at approximately $263.82 million, which represents 4.1% of their overall portfolio.
• Several institutional investors, including Brown Advisory Inc. and Farther Finance Advisors LLC, have increased their positions in HCA Healthcare, indicating strong interest in the company among institutional investors.
• HCA Healthcare has a current stock price of $390.34, with a market capitalization of $91.34 billion and recently announced a quarterly dividend of $0.72 per share, reflecting a 0.7% dividend yield.

Lyrical Asset Management LP lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 763,468 shares of the company's stock after selling 8,223 shares during the period. HCA Healthcare comprises approximately 4.1% of Lyrical Asset Management LP's holdings, making the stock its 11th largest holding. Lyrical Asset Management LP owned about 0.32% of HCA Healthcare worth $263,816,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Cheviot Value Management LLC purchased a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $28,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the last quarter. ORG Partners LLC grew its stake in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its position in HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA stock traded down $1.94 during trading on Monday, reaching $393.86. The company's stock had a trading volume of 1,014,488 shares, compared to its average volume of 1,573,874. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $92.16 billion, a P/E ratio of 16.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.39. The company's fifty day moving average is $370.53 and its 200-day moving average is $351.75.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $5.50 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Stephens raised HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Barclays lowered their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research report on Monday, July 28th. Royal Bank Of Canada lowered their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Finally, Wells Fargo & Company lowered their price target on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday. Nine research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $398.58.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.